The Early Access to Medicines Scheme (EAMS) aims to make promising new medicines available to patients sooner. It was set up in 2014 and is run by the Medicines and Healthcare Products Regulatory Agency (MHRA).
The Early Access to Medicines Scheme (EAMS) gives people access to promising new drugs that are not yet licensed.
There are safety measures in place if you have a drug through the Early Access to Medicines Scheme (EAMS).
We know it’s a worrying time for people with cancer, we have information to help.
Read our information about coronavirus and cancer
About Cancer generously supported by Dangoor Education since 2010.
Search our clinical trials database for all cancer trials and studies recruiting in the UK
Talk to other people affected by cancer
Questions about cancer? Call freephone 9 to 5 Monday to Friday or email us